Anticonvulsant mechanisms of the ketogenic diet

Epilepsia

Volumn 48, Issue 1, 2007, Pages 43-58

  Bough, Kristopher J ^a   Rho, Jong M ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Epilepsy; Ketogenic diet; Metabolism; Polyunsaturated fatty acids

Indexed keywords

3 HYDROXYBUTYRIC ACID; 4 AMINOBUTYRIC ACID; ACETOACETIC ACID DERIVATIVE; ACETONE; ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; ICOSAPENTAENOIC ACID; KETONE; NEUROTRANSMITTER; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN;

ANTICONVULSANT ACTIVITY; ATONIC SEIZURE; BIOGENESIS; BRAIN; BRAIN MITOCHONDRION; BRAIN TISSUE; CITRIC ACID CYCLE; CLINICAL EFFECTIVENESS; CLINICAL STUDY; DIET RESTRICTION; DISEASE SEVERITY; DRUG MECHANISM; ENERGY METABOLISM; ENERGY YIELD; EPILEPSY; EXPERIMENTAL STUDY; GLIA CELL; GLUCOSE RESTRICTION; HUMAN; HYPERPOLARIZATION; KETOACIDOSIS; KETOGENIC DIET; NERVE CELL; NONHUMAN; NORADRENERGIC SYSTEM; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNAPSE; SYNAPTIC EFFICACY; UPREGULATION;

DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ENERGY METABOLISM; EPILEPSY; HUMANS; KETONE BODIES; KETOSIS; REACTIVE OXYGEN SPECIES; TREATMENT OUTCOME;

EID: 33846250398     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2007.00915.x     Document Type: Review

References (154)

1. Al-Mudallal AS, LaManna JC, Lust WD, Harik SI. (1996) Diet-induced ketosis does not cause cerebral acidosis. Epilepsia 37:258-261.
2. Andrews ZB, Diano S, Horvath TL. (2005) Mitochondrial uncoupling proteins in the cns: in support of function and survival. Nature Reviews Neuroscience 6:829-840.
3. Antozzi C, Franceschetti S, Filippini G, Barbiroli B, Savoiardo M, Fiacchino F, Rimoldi M, Lodi R, Zaniol P, Zeviani M. (1995) Epilepsia partialis continua associated with nadh-coenzyme q reductase deficiency. Journal of the Neurological Sciences 129:152-161.
4. Appleton DB, DeVivo DC. (1974) An animal model for the ketogenic diet. Epilepsia 15:211-227.
5. Attwell D, Laughlin SB. (2001) An energy budget for signaling in the grey matter of the brain. Journal of Cerebral Blood Flow and Metabolism 21:1133-1145.
6. Avellini L, Terracina L, Gaiti A. (1994) Linoleic acid passage through the blood-brain barrier and a possible effect of age. Neurochemical Research 19:129-133.
7. Boero J, Qin W, Cheng J, Woolsey TA, Strauss AW, Khuchua Z. (2003) Restricted neuronal expression of ubiquitous mitochondrial creatine kinase: changing patterns in development and with increased activity. Molecular and Cellular Biochemistry 244:69-76.
8. Bough KJ, Chen RS, Eagles DA. (1999a) Path analysis shows that increasing ketogenic ratio, but not beta-hydroxybutarate, elevates seizure threshold in the rat. Developmental Neuroscience 21:400-406.
9. Bough KJ, Eagles DA. (1999) A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 40:138-143.
10. Bough KJ, Valiyil R, Han FT, Eagles DA. (1999b) Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet. Epilepsy Research 35:21-28.
11. Bough KJ, Matthews PJ, Eagles DA. (2000a) A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion. Epilepsy Research 38:105-114.
12. Bough KJ, Yao SG, Eagles DA. (2000b) Higher ketogenic diet ratios confer protection from seizures without neurotoxicity. Epilepsy Research 38:15-25.
13. Bough KJ, Gudi K, Han FT, Rathod AH, Eagles DA. (2002) An anticonvulsant profile of the ketogenic diet in the rat. Epilepsy Research 50:313-325.
14. Bough KJ, Schwartzkroin PA, Rho JM. (2003) Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia 44:752-760.
15. Bough KJ, Wetherington J, Hassel B, Pare JF, Gawryluk JW, Greene JG, Shaw R, Smith Y, Geiger JD, Dingledine RJ. (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology 60:223-235.
16. Cheng CM, Hicks K, Wang J, Eagles DA, Bondy CA. (2004) Caloric restriction augments brain glutamic acid decarboxylase-65 and -67 expression. Journal of Neuroscience Research 77:270-276.
17. Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Dionisi-Vici C, Elia M, Lispi ML, Sarnelli C, Tagliabue A, Toraldo C, Pascotto A. (2002) The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an italian multicentric experience. Epilepsy Research 48:221-227.
18. Cullingford TE. (2004) The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 70:253-264.
19. Cunnane SC, Musa K, Ryan MA, Whiting S, Fraser DD. (2002) Potential role of polyunsaturates in seizure protection achieved with the ketogenic diet. Prostaglandins Leukot Essent Fatty Acids 67:131-135.
20. Cunnane SC. (2004) Metabolism of polyunsaturated fatty acids and ketogenesis: an emerging connection. Prostaglandins Leukot Essent Fatty Acids 70:237-241.
21. Dahlin M, Elfving A, Ungerstedt U, Amark P. (2005) The ketogenic diet influences the levels of excitatory and inhibitory amino acids in the csf in children with refractory epilepsy. Epilepsy Research 64:115-125.
22. Dekaban AS. (1966) Plasma lipids in epileptic children treated with the high fat diet. Archives of Neurology 15:177-184.
23. Dell CA, Likhodii SS, Musa K, Ryan MA, Burnham WM, Cunnane SC. (2001) Lipid and fatty acid profiles in rats consuming different high-fat ketogenic diets. Lipids 36:373-378.
24. Depondt C, Shorvon SD. (2006) Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications. Pharmacogenomics 7:731-745.
25. DeVivo DC, Leckie MP, Ferrendelli JS, McDougal DB Jr. (1978) Chronic ketosis and cerebral metabolism. Annals of Neurology 3:331-337.
26. Dhar-Chowdhury P, Harrell MD, Han SY, Jankowska D, Parachuru L, Morrissey A, Srivastava S, Liu W, Malester B, Yoshida H, Coetzee WA. (2005) The glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the k(atp) channel macromolecular complex and regulate its function. The Journal of Biological Chemistry 280:38464-38470.
27. Diano S, Matthews RT, Patrylo P, Yang L, Beal MF, Barnstable CJ, Horvath TL. (2003) Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 144:5014-5021.
28. Donevan SD, White HS, Anderson GD, Rho JM. (2003) Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of l-(+)-beta-hydroxybutyrate. Epilepsia 44:1274-1279.
29. Dubinsky WP, Mayorga-Wark O, Schultz SG. (1998) Colocalization of glycolytic enzyme activity and katp channels in basolateral membrane of necturus enterocytes. The American Journal of Physiology 275:C1653-1659.
30. Eagles DA, Boyd SJ, Kotak A, Allan F. (2003) Calorie restriction of a high-carbohydrate diet elevates the threshold of ptz-induced seizures to values equal to those seen with a ketogenic diet. Epilepsy Research 54:41-52.
31. Erecinska M, Nelson D, Daikhin Y, Yudkoff M. (1996) Regulation of gaba level in rat brain synaptosomes: fluxes through enzymes of the gaba shunt and effects of glutamate, calcium, and ketone bodies. Journal of Neurochemistry 67:2325-2334.
32. Franks NP, Honore E. (2004) The trek k2p channels and their role in general anaesthesia and neuroprotection. Trends in Pharmacological Sciences 25:601-608.
33. Fraser DD, Whiting S, Andrew RD, Macdonald EA, Musa-Veloso K, Cunnane SC. (2003) Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology 60:1026-1029.
34. Freeman J, Veggiotti P, Lanzi G, Tagliabue A, Perucca E. (2006) The ketogenic diet: from molecular mechanisms to clinical effects. Epilepsy Research 68:145-180.
35. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. (1998) The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102:1358-1363.
36. Freeman JM, Vining EP. (1999) Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet. Archives of Pediatrics & Adolescent Medicine 153:946-949.
37. Freeman JM, Kelley MT, Freeman JB. (2000) The ketogenic diet: a treatment for epilepsy, 3rd ed. Demos, New York.
38. Fuehrlein BS, Rutenberg MS, Silver JN, Warren MW, Theriaque DW, Duncan GE, Stacpoole PW, Brantly ML. (2004) Differential metabolic effects of saturated versus polyunsaturated fats in ketogenic diets. The Journal of Clinical Endocrinology and Metabolism 89:1641-1645.
39. Garlid KD, Jaburek M, Jezek P. (2001) Mechanism of uncoupling protein action. Biochemical Society Transactions 29:803-806.
40. Garriga-Canut M, Schoenike B, Qazi R, Bergendahl K, Daley TJ, Pfender RM, Morrison JF, Ockuly J, Stafstrom CE, Sutula T, Roopra A. (2006) 2-deoxy-d-glucose reduces epilepsy progression by nrsf-ctbp-dependent metabaolic regulation of chromatin structure. Nature Neuroscience 9:1382-1387.
41. Giorgi FS, Pizzanelli C, Biagioni F, Murri L, Fornai F. (2004) The role of norepinephrine in epilepsy: from the bench to the bedside. Neuroscience and Biobehavioral Reviews 28:507-524.
42. Greene AE, Todorova MT, McGowan R, Seyfried TN. (2001) Caloric restriction inhibits seizure susceptibility in epileptic el mice by reducing blood glucose. Epilepsia 42:1371-1378.
43. Greene AE, Todorova MT, Seyfried TN. (2003) Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. Journal of Neurochemistry 86:529-537.
44. Helmholz HF, Keith HM. (1930) Eight years' experience with the ketogenic diet in the treatment of epilepsy. Journal of the American Medical Association 95:707-709.
45. Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA. (2006) Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. Journal of Child Neurology 21:193-198.
46. Hernandez-Sanchez C, Basile AS, Fedorova I, Arima H, Stannard B, Fernandez AM, Ito Y, LeRoith D. (2001) Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death. Proceedings of the National Academy of Sciences of the United States of America 98:3549-3554.
47. 3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain. Neuroscience 61:285-292.
48. Hold KM, Sirisoma NS, Ikeda T, Narahashi T, Casida JE. (2000) Alpha-thujone (the active component of absinthe): gamma-aminobutyric acid type a receptor modulation and metabolic detoxification. Proceedings of the National Academy of Sciences of the United States of America 97:3826-3831.
49. Hori A, Tandon P, Holmes GL, Stafstrom CE. (1997) Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia 38:750-758.
50. Hulbert AJ, Else PL. (2000) Mechanisms underlying the cost of living in animals. Annual Review of Physiology 62:207-235.
51. Huttenlocher PR, Wilbourn AJ, Signore JM. (1971) Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 21:1097-1103.
52. Huttenlocher PR. (1976) Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatric Research 10:536-540.
53. Iadarola MJ, Gale K. (1982) Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science 218:1237-1240.
54. Jaburek M, Varecha M, Gimeno RE, Dembski M, Jezek P, Zhang M, Burn P, Tartaglia LA, Garlid KD. (1999) Transport function and regulation of mitochondrial uncoupling proteins 2 and 3. The Journal of Biological Chemistry 274:26003-26007.
55. Jovanovic S, Du Q, Crawford RM, Budas GR, Stagljar I, Jovanovic A. (2005) Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal k(atp) channel. EMBO Reports 6:848-852.
56. Kann O, Kovacs R, Njunting M, Behrens CJ, Otahal J, Lehmann TN, Gabriel S, Heinemann U. (2005) Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain 128:2396-2407.
57. Kashiwaya Y, Takeshima T, Mori N, Nakashima K, Clarke K, Veech RL. (2000) D-beta-hydroxybutyrate protects neurons in models of alzheimer's and parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 97:5440-5444.
58. Keith HM. (1933) Factors influencing experimentally produced convulsions. Archives of Neurology Psychiatry 29:148-154.
59. Kinsman SL, Vining EP, Quaskey SA, Mellits D, Freeman JM. (1992) Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 33:1132-1136.
60. Kossoff EH, Pyzik PL, McGrogan JR, Vining EP, Freeman JM. (2002) Efficacy of the ketogenic diet for infantile spasms. Pediatrics 109:780-783.
61. Kossoff EH, Krauss GL, McGrogan JR, Freeman JM. (2003) Efficacy of the atkins diet as therapy for intractable epilepsy. Neurology 61:1789-1791.
62. Kossoff EH, McGrogan JR. (2005) Worldwide use of the ketogenic diet. Epilepsia 46:280-289.
63. Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. (2006) A modified atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia 47:421-424.
64. Kovacs R, Schuchmann S, Gabriel S, Kardos J, Heinemann U. (2001) Ca2+ signalling and changes of mitochondrial function during low-mg2+-induced epileptiform activity in organotypic hippocampal slice cultures. The European Journal of Neuroscience 13:1311-1319.
65. Kovacs R, Schuchmann S, Gabriel S, Kann O, Kardos J, Heinemann U. (2002) Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. Journal of Neurophysiology 88:2909-2918.
66. Kudin AP, Kudina TA, Seyfried J, Vielhaber S, Beck H, Elger CE, Kunz WS. (2002) Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. The European Journal of Neuroscience 15:1105-1114.
67. Kunz WS, Kudin AP, Vielhaber S, Blumcke I, Zuschratter W, Schramm J, Beck H, Elger CE. (2000) Mitochondrial complex i deficiency in the epileptic focus of patients with temporal lobe epilepsy. Annals of Neurology 48:766-773.
68. Layton ME, Pazdernik TL. (1999) Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats. Journal of Molecular Neuroscience 13:63-68.
69. Leaf A, Kang JX. (1996) Prevention of cardiac sudden death by n-3 fatty acids: a review of the evidence. Journal of Internal Medicine 240:5-12.
70. Leaf A, Xiao YF, Kang JX, Billman GE. (2003) Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacology & Therapeutics 98:355-377.
71. Lesage F. (2003) Pharmacology of neuronal background potassium channels. Neuropharmacology 44:1-7.
72. Likhodii S, Burnham WM. (2004) Epilepsy and the ketogenic diet. In-Stafstrom CE, Rho JM (Eds). The effects of ketone bodies on neuronal excitability. Humana Press, Inc., Totowa, NJ, pp. 217-228.
73. Likhodii SS, Musa K, Mendonca A, Dell C, Burnham WM, Cunnane SC. (2000) Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia 41:1400-1410.
74. Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC, III, Burnham WM. (2003) Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Annals of Neurology 54:219-226.
75. Livingston S. (1972) Comprehensive management of epilepsy in infancy, childhood and adolescence. In Livingston S (Ed) Dietary treatment of epilepsy. Charles C. Thomas, Springfield, IL, pp. 378-405.
76. Mady MA, Kossoff EH, McGregor AL, Wheless JW, Pyzik PL, Freeman JM. (2003) The ketogenic diet: adolescents can do it, too. Epilepsia 44:847-851.
77. Mahoney AW, Hendricks DG, Bernhard N, Sisson DV. (1983) Fasting and ketogenic diet effects on audiogenic seizures susceptibility of magnesium deficient rats. Pharmacology, Biochemistry, and Behavior 18:683-687.
78. Mak SC, Chi CS, Wan CJ. (1999) Clinical experience of ketogenic diet on children with refractory epilepsy. Acta Paediatrica Taiwanica 40:97-100.
79. Melo TM, Nehlig A, Sonnewald U. (2006) Neuronal-glial interactions in rats fed a ketogenic diet. Neurochemistry International 48:498-507.
80. Millichap JG, Jones JD, Rudis BP. (1964) Mechanism of anticonvulsant action of ketogenic diet. American Journal of Diseases of Children 107:593-604.
81. Morris AA. (2005) Cerebral ketone body metabolism. Journal of Inherited Metabolic Disease 28:109-121.
82. Muller-Schwarze AB, Tandon P, Liu Z, Yang Y, Holmes GL, Stafstrom CE. (1999) Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10:1517-1522.
83. Nakazawa M, Kodama S, Matsuo T. (1983) Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain & Development 5:375-380.
84. Noh HS, Lee HP, Kim DW, Kang SS, Cho GJ, Rho JM, Choi WS. (2004) A cdna microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Brain Research. Molecular Brain Research 129:80-87.
85. Noh HS, Hah YS, Nilufar R, Han J, Bong JH, Kang SS, Cho GJ, Choi WS. (2006) Acetoacetate protects neuronal cells from oxidative glutamate toxicity. Journal of Neuroscience Research 83:702-709.
86. Nordli DR, Jr., Kuroda MM, Carroll J, Koenigsberger DY, Hirsch LJ, Bruner HJ, Seidel WT, De Vivo DC. (2001) Experience with the ketogenic diet in infants. Pediatrics 108:129-133.
87. Nordoy A. (1999) Dietary fatty acids and coronary heart disease. Lipids 34(suppl):S19-22.
88. Otani K, Yamatodani A, Wada H, Mimaki T, Yabuuchi H. (1984) [Effect of ketogenic diet on the convulsive threshold and brain amino acid and monoamine levels in young mice]. No To Hattatsu 16:196-204.
89. Pan JW, Bebin EM, Chu WJ, Hetherington HP. (1999) Ketosis and epilepsy: 31p spectroscopic imaging at 4.1 t. Epilepsia 40:703-707.
90. Pelicano H, Martin DS, Xu RH, Huang P. (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633-4646.
91. Peterson SJ, Tangney CC, Pimentel-Zablah EM, Hjelmgren B, Booth G, Berry-Kravis E. (2005) Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. Journal of the American Dietetic Association 105:718-725.
92. Puchowicz MA, Emancipator DS, Xu K, Magness DL, Ndubuizu OI, Lust WD, LaManna JC. (2005) Adaptation to chronic hypoxia during diet-induced ketosis. Advances in Experimental Medicine and Biology 566:51-57.
93. Rhim H, Kinney GA, Emmerson PJ, Miller RJ. (1997) Regulation of neurotransmission in the arcuate nucleus of the rat by different neuropeptide y receptors. The Journal of Neuroscience 17:2980-2989.
94. Rho JM, Kim DW, Robbins CA, Anderson GD, Schwartzkroin PA. (1999) Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Research 37:233-240.
95. Rho JM, Anderson GD, Donevan SD, White HS. (2002) Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 43:358-361.
96. Richichi C, Lin EJ, Stefanin D, Colella D, Ravizza T, Grignaschi G, Veglianese P, Sperk G, During MJ, Vezzani A. (2004) Anticonvulsant and antiepileptogenic effects mediated by adeno-associated virus vector neuropeptide y expression in the rat hippocampus. The Journal of Neuroscience 24:3051-3059.
97. Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hokfelt T, Wasterlain C, Bartfai T, Langel U. (2002) Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proceedings of the National Academy of Sciences of the United States of America 99:7136-7141.
98. Sampath H, Ntambi JM. (2004) Polyunsaturated fatty acid regulation of gene expression. Nutrition Reviews 62:333-339.
99. Sampath H, Ntambi JM. (2005) Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annual Review of Nutrition 25:317-340.
100. Sato K, Kashiwaya Y, Keon CA, Tsuchiya N, King MT, Radda GK, Chance B, Clarke K, Veech RL. (1995) Insulin, ketone bodies, and mitochondrial energy transduction. The FASEB Journal 9:651-658.
101. Schlanger S, Shinitzky M, Yam D. (2002) Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia 43:103-104.
102. Schlifke I, Kuteeva E, Hokfelt T, Kokaia M. (2006) Galanin expressed in the excitatory fibers attenuates synaptic strength and generalized seizures in the piriform cortex of mice. Experimental Neurology 200:398-406.
103. Schwartz RH, Eaton J, Bower BD, Aynsley-Green A. (1989a) Ketogenic diets in the treatment of epilepsy: short-term clinical effects. Developmental Medicine and Child Neurology 31:145-151.
104. Schwartz RM, Boyes S, Aynsley-Green A. (1989b) Metabolic effects of three ketogenic diets in the treatment of severe epilepsy. Developmental Medicine and Child Neurology 31:152-160.
105. Schwartzkroin PA. (1999) Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Research 37:171-180.
106. Seino S, Miki T. (2003) Physiological and pathophysiological roles of atp-sensitive k+ channels. Progress in Biophysics and Molecular Biology 81:133-176.
107. Seymour KJ, Bluml S, Sutherling J, Sutherling W, Ross BD. (1999) Identification of cerebral acetone by 1h-mrs in patients with epilepsy controlled by ketogenic diet. Magma 8:33-42.
108. Shyng SL, Nichols CG. (1998) Membrane phospholipid control of nucleotide sensitivity of katp channels. Science 282:1138-1141.
109. Sills MA, Forsythe WI, Haidukewych D, MacDonald A, Robinson M. (1986) The medium chain triglyceride diet and intractable epilepsy. Archives of Disease in Childhood 61:1168-1172.
110. Sirven J, Whedon B, Caplan D, Liporace J, Glosser D, O'Dwyer J, Sperling MR. (1999) The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia 40:1721-1726.
111. Smith SL, Heal DJ, Martin KF. (2005) Ktx 0101: a potential metabolic approach to cytoprotection in major surgery and neurological disorders. CNS Drug Reviews 11:113-140.
112. Spurr NK. (2006) Pharmacogenetic studies of epilepsy drugs: are we there yet? Trends in Genetics 22:250-252.
113. Stafstrom CE. (1999) Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Research 37:241-259.
114. Stafstrom CE. (2004) Dietary approaches to epilepsy treatment: old and new options on the menu. Epilepsy Currents 4:215-222.
115. Stafstrom CE, Kriegler SM, Valley MT, Ockuly JC, Roopra AS, Sutula TP. (2005) 2-deoxyglucose exerts anticonvulsant and antiepileptic actions in experimental epilepsy models. Epilepsia 46:268-269.
116. Su SW, Cilio MR, Sogawa Y, Silveira DC, Holmes GL, Stafstrom CE. (2000) Timing of ketogenic diet initiation in an experimental epilepsy model. Brain Research Developmental Brain Research 125:131-138.
117. Sullivan PG, Dube C, Dorenbos K, Steward O, Baram TZ. (2003) Mitochondrial uncoupling protein-2 protects the immature brain from excitotoxic neuronal death. Annals of Neurology 53:711-717.
118. Sullivan PG, Rippy NA, Dorenbos K, Concepcion RC, Agarwal AK, Rho JM. (2004) The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Annals of Neurology 55:576-580.
119. Szot P, Weinshenker D, Rho JM, Storey TW, Schwartzkroin PA. (2001) Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Research Developmental Brain Research 129:211-214.
120. Tabb K, Szot P, White SS, Liles LC, Weinshenker D. (2004) The ketogenic diet does not alter brain expression of orexigenic neuropeptides. Epilepsy Research 62:35-39.
121. Taha AY, Ryan MA, Cunnane SC. (2005) Despite transient ketosis, the classic high-fat ketogenic diet induces marked changes in fatty acid metabolism in rats. Metabolism 54:1127-1132.
122. Thavendiranathan P, Mendonca A, Dell C, Likhodii SS, Musa K, Iracleous C, Cunnane SC, Burnham WM. (2000) The mct ketogenic diet: effects on animal seizure models. Experimental Neurology 161:696-703.
123. Thavendiranathan P, Chow C, Cunnane S, McIntyre BW. (2003) The effect of the 'classic' ketogenic diet on animal seizure models. Brain Research 959:206-213.
124. Thio LL, Wong M, Yamada KA. (2000) Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54:325-331.
125. Thio LL, Erbayat-Altay E, Rensing N, Yamada KA. (2006) Leptin contributes to slower weight gain in juvenile rodents on a ketogenic diet. Pediatric Research.
126. Thomzig A, Laube G, Pruss H, Veh RW. (2005) Pore-forming subunits of k-atp channels, kir6.1 and kir6.2, display prominent differences in regional and cellular distribution in the rat brain. The Journal of Comparative Neurology 484:313-330.
127. Uhlemann ER, Neims AH. (1972) Anticonvulsant properties of the ketogenic diet in mice. The Journal of Pharmacology and Experimental Therapeutics 180:231-238.
128. Vamecq J, Vallee L, Lesage F, Gressens P, Stables JP. (2005) Antiepileptic popular ketogenic diet: emerging twists in an ancient story. Progress in Neurobiology 75:1-28.
129. Veech RL, Chance B, Kashiwaya Y, Lardy HA, Cahill GF Jr. (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51:241-247.
130. Veech RL. (2004) The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70:309-319.
131. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, De Simoni MG, Sperk G, Andell-Jonsson S, Lundkvist J, Iverfeldt K, Bartfai T. (2000) Powerful anticonvulsant action of il-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proceedings of the National Academy of Sciences of the United States of America 97:11534-11539.
132. Vezzani A, Sperk G. (2004) Overexpression of npy and y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy? Neuropeptides 38:245-252.
133. Vining EP, Freeman JM, Ballaban-Gil K, Camfield CS, Camfield PR, Holmes GL, Shinnar S, Shuman R, Trevathan E, Wheless JW. (1998) A multicenter study of the efficacy of the ketogenic diet. Archives of Neurology 55:1433-1437.
134. Vining EP. (1999) Clinical efficacy of the ketogenic diet. Epilepsy Research 37:181-190.
135. Vining EP, Pyzik P, McGrogan J, Hladky H, Anand A, Kriegler S, Freeman JM. (2002) Growth of children on the ketogenic diet. Developmental Medicine and Child Neurology 44:796-802.
136. Vodickova L, Frantik E, Vodickova A. (1995) Neutrotropic effects and blood levels of solvents at combined exposures: binary mixtures of toluene, o-xylene and acetone in rats and mice. Central European Journal of Public Health 3:57-64.
137. Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ. (1996) Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proceedings of the National Academy of Sciences of the United States of America 93:12559-12563.
138. Wang ZJ, Bergqvist C, Hunter JV, Jin D, Wang DJ, Wehrli S, Zimmerman RA. (2003) In vivo measurement of brain metabolites using two-dimensional double-quantum mr spectroscopy-exploration of gaba levels in a ketogenic diet. Magnetic Resonance in Medicine 49:615-619.
139. Weinshenker D, Szot P. (2002) The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacology & Therapeutics 94:213-233.
140. Williamson A, Patrylo PR, Pan J, Spencer DD, Hetherington H. (2005) Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy. Brain 128:1199-1208.
141. Wu BJ, Hulbert AJ, Storlien LH, Else PL. (2004) Membrane lipids and sodium pumps of cattle and crocodiles: an experimental test of the membrane pacemaker theory of metabolism. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 287:R633-641.
142. Xiao Y, Li X. (1999) Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Research 846:112-121.
143. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. (1997) Suppression of voltage-gated l-type ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proceedings of the National Academy of Sciences of the United States of America 94:4182-4187.
144. Xiao YF, Wright SN, Wang GK, Morgan JP, Leaf A. (1998) Fatty acids suppress voltage-gated Na+ currents in hek293t cells transfected with the alpha-subunit of the human cardiac Na+ channel. Proceedings of the National Academy of Sciences of the United States of America 95:2680-2685.
145. Xiong ZQ, Stringer JL. (2000) Sodium pump activity, not glial spatial buffering, clears potassium after epileptiform activity induced in the dentate gyrus. Journal of Neurophysiology 83:1443-1451.
146. Yamada K, Ji JJ, Yuan H, Miki T, Sato S, Horimoto N, Shimizu T, Seino S, Inagaki N. (2001) Protective role of atp-sensitive potassium channels in hypoxia-induced generalized seizure. Science 292:1543-1546.
147. Yamashita M, Matsuki A, Oyama T. (1976) General anaesthesia for a patient with progressive muscular dystrophy. Anaesthesist 25:76-79.
148. Yan QS, Jobe PC, Dailey JW. (1993) Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Research 610:24-31.
149. Young C, Gean PW, Chiou LC, Shen YZ. (2000) Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse 37:90-94.
150. Yudkoff M, Daikhin Y, Nissim I, Grunstein R. (1997) Effects of ketone bodies on astrocyte amino acid metabolism. Journal of Neurochemistry 69:682-692.
151. Yudkoff M, Daikhin Y, Nissim I, Lazarow A. (2001) Brain amino acid metabolism and ketosis. The Journal of Neuroscience Journal of Neuroscience Research 66:272-281.
152. Yudkoff M, Daikhin Y, Nissim I, Nissim I. (2004) Epilepsy and the ketogenic diet. In Stafstrom CE, Rho JM (Eds) The ketogenic diet: interactions with brain amino acid handling. Humana Press, Inc., Totowa, NJ, pp. 185-215.
153. Yudkoff M, Daikhin Y, Nissim I, Horyn O, Lazarow A, Luhovyy B, Wehrli S. (2005) Response of brain amino acid metabolism to ketosis. Neurochemistry International 47:119-128.
154. Yuen AW, Sander JW, Fluegel D, Patsalos PN, Bell GS, Johnson T, Koepp MJ. (2005) Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy & Behavior 7:253-258.